CDRH has been concerned about genAI-enabled medical devices for some time. Following a November 2024 public meeting of its Digital Health Advisory Committee, CDRH identified two categories of ...
On July 14, the U.S. Food and Drug Administration (FDA) announced it is seeking public input regarding the patient safety impacts of certain medical software functions excluded from the definition of ...